Physician profile
Lindsay A Larson
NPI 1851618151
$7,751.28
in general payments reported to CMS, 2019-2025
53 companies · $1,666 in 2025
The $1,666 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $549 · 2020: $85.38 · 2021: $509 · 2022: $1,321 · 2023: $1,765 · 2024: $1,856 · 2025: $1,666.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,286.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $967.88 | 2019-2025 | Benlysta, Trelegy Ellipta, Shingrix |
| Pfizer INC. | $666.07 | 2019-2025 | |
| Astellas Pharma US INC | $617.85 | 2021-2025 | Veozah, Myrbetriq |
| Genzyme Corporation | $606.19 | 2021-2025 | |
| Lilly USA, LLC | $568.07 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $501.71 | 2019-2025 | Farxiga, Airsupra |
| Novo Nordisk INC | $461.74 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $312.10 | 2021-2025 | Jardiance, Ofev |
| Bayer Healthcare Pharmaceuticals INC. | $263.92 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $225.47 | 2019-2025 | Gardasil 9, Capvaxive, Vaxneuvance |
| Phathom Pharmaceuticals, INC. | $203.79 | 2024-2025 | Voquezna |
| Regeneron Healthcare Solutions, INC. | $190.72 | 2023-2025 | Dupixent |
| Gilead Sciences, INC. | $148.75 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $141.74 | 2024-2025 | Gemtesa |
| Novartis Pharmaceuticals Corporation | $138.09 | 2021-2023 |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $117.24 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $111.15 | 2021-2024 | Jynarque |
| Biohaven Pharmaceutical Holding Company LTD. | $105.77 | 2022 | |
| Dexcom, INC. | $95.15 | 2023-2024 | Dexcom G6 Transmitter |
| Sun Pharmaceutical Industries INC. | $90.57 | 2025 | |
| Fresenius Kabi USA, LLC | $86.68 | 2023-2024 | Idacio |
| Amgen INC. | $76.51 | 2020-2025 | Evenity, Tepezza, Prolia |
| Abbott Laboratories | $76.49 | 2022-2023 | Freestyle Libre 3, Freestyle Libre 2 |
| Ucb, INC. | $71.72 | 2021-2025 | Bimzelx |
| Hologic Sales and Service, LLC | $67.66 | 2019-2025 | Thinprep 2000 Processor, Aptima |
| Horizon Therapeutics Plc | $58.56 | 2021 | |
| Mallinckrodt Hospital Products INC. | $51.36 | 2021-2022 | |
| Boston Scientific Corporation | $50.70 | 2020-2024 | Watchman Flx |
| Sanofi-Aventis U.S. LLC | $49.07 | 2024 | |
| Janssen Biotech, INC. | $47.15 | 2022-2025 | Tremfya, Simponi Aria, Stelara |
| Sanofi Pasteur INC. | $46.68 | 2022-2023 | |
| Allergan, INC. | $40.84 | 2020 | |
| Exact Sciences Corporation | $38.73 | 2023-2024 | Cologuard Collection Kit |
| Zyla Life Sciences, INC. | $36.07 | 2019 | |
| Janssen Pharmaceuticals, INC | $34.55 | 2019 | |
| Biosense Webster, INC. | $31.10 | 2024 | Qdot Micro Catheter |
| Averitas Pharma INC. | $30.77 | 2024 | Qutenza |
| Kiniksa Pharmaceuticals International, Plc | $29.89 | 2024 | Arcalyst |
| Seqirus USA INC | $28.63 | 2024-2025 | Flucelvax, Fluad |
| Alexion Pharmaceuticals, INC. | $25.57 | 2025 | Ultomiris |
| Ibsa Pharma INC. | $22.33 | 2024 | Licart, Tirosint |
| Scilex Pharmaceuticals INC. | $21.26 | 2019 | |
| Ascensia Diabetes Care US INC. | $21.15 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $20.68 | 2023 | Eliquis |
| Shield Therapeutics INC | $20.46 | 2023 | Accrufer |
| Biohaven Pharmaceuticals, INC. | $19.35 | 2021 | |
| Bausch Health US, LLC | $19.24 | 2019 | |
| Lucid Diagnostics INC. | $18.53 | 2022 | |
| Linus Health, INC. | $17.99 | 2022 | |
| Idorsia Pharmaceuticals US INC | $16.46 | 2022 | |
| Arbor Pharmaceuticals, INC. | $15.46 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $13.88 | 2022 | |
| Eisai INC. | $11.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsay Larson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.